Summary of COVID-19 vaccine-related reports in the vaccine adverse event reporting system
Identification of the severe acute respiratory syndrome coronavirus 2 in humans toward the end of 2019 triggered a rapid, intensive effort to develop a vaccine.Among the first three COVID-19 vaccines granted emergency use authorization by the U.S.Food and Drug Administration (FDA) were two mRNA vaccines, never used on a large scale in humans, and o